This blog post is part of the Community Viewpoint series. It talks about how the diabetes healthcare community views the inhaled insulin Afrezza. This is the product Mannkind Corporation calls “Outsulin.” The View of “Outsulin” Healthcare providers I know still have not heard of “Outsulin”. Outsulin is the latest marketing campaign from Mannkind Corporation. The campaign explains “Three hours after you take AFREZZA, your blood sugar returns […]

Read more